2024 annual financial data
Metagenomi Therapeutics 2024 Revenue growth
Direct answer
Revenue growth was 16.84%.
Operating income was -88,901,000 USD and net income was -78,058,000 USD.
Operating cash flow was -109,073,000 USD.
Get free Metagenomi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 52,295,000 USD
- Operating income
- -88,901,000 USD
- Net income
- -78,058,000 USD
- Operating cash flow
- -109,073,000 USD